TABLE 2.
Baseline characteristics for subjects in the trans fat (IP-TFA; n = 24) and control (CTR, n = 25) groups and for lean references (lean ref.; n = 19)
| IP-TFA | CTR | Lean ref. | |
| Age (y) | 58.5 ± 4.6 | 58.8 ± 5.5 | 60.1 ± 5.9 |
| Height (cm) | 165.3 ± 5.5 | 166.9 ± 5.2 | 166.7 ± 4.3 |
| Weight (kg) | 78.7 ± 7.1 | 78.4 ± 8.6 | 59.4 ± 4.8 a |
| BMI (kg/m ) | 28.8 ± 1.7 | 28.1 ± 2.2 | 21.3 ± 1.4 a |
| Waist circumference (cm) | 97.1 ± 7.3 | 95.5 ± 6.8 | 74.9 ± 3.8 a |
| Urine 8-iso-PGF2α (nmol/mmol creatinine) | 0.28 (0.24; 0.32) | 0.31 (0.24; 0.43) | 0.35 (0.28; 0.41) |
Values are means ± SD or geometric means (95%CI) for skewed data, completers only. BMI, body mass index; 8-iso-PGF2α, 8-iso-prostaglandin-F2α.
a
Significantly different from overweight intervention subjects (diet groups combined) by 2-tailed unpaired t-tests (P < 0.05).